PRMT5 methylating SMAD4 activates TGF-β signaling and promotes colorectal cancer metastasis

[1]  Yongdong Feng,et al.  EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis , 2022, The Journal of clinical investigation.

[2]  Tianshu Yang,et al.  Snail/PRMT5/NuRD complex contributes to DNA hypermethylation in cervical cancer by TET1 inhibition , 2021, Cell Death & Differentiation.

[3]  F. Gonzalez,et al.  Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma , 2021, Hepatology.

[4]  C. Arrowsmith,et al.  Protein arginine methylation: from enigmatic functions to therapeutic targeting , 2021, Nature Reviews Drug Discovery.

[5]  Yongdong Feng,et al.  NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein , 2021, Oncogene.

[6]  Di Wu,et al.  PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma , 2020, Cell Death & Disease.

[7]  Z. Ronai,et al.  PRMT5 function and targeting in cancer , 2020, Cell stress.

[8]  R. Pearson,et al.  Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma , 2019, Proceedings of the National Academy of Sciences.

[9]  S. Richard,et al.  The regulation, functions and clinical relevance of arginine methylation , 2019, Nature Reviews Molecular Cell Biology.

[10]  F. Lyko,et al.  The importance of non-histone protein methylation in cancer therapy , 2019, Nature Reviews Molecular Cell Biology.

[11]  Clare C. Davies,et al.  PRMTs and Arginine Methylation: Cancer's Best-Kept Secret? , 2019, Trends in molecular medicine.

[12]  P. ten Dijke,et al.  TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis , 2019, International journal of molecular sciences.

[13]  Michael L. Wang,et al.  PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells , 2019, Leukemia.

[14]  Eduard Batlle,et al.  Transforming Growth Factor-β Signaling in Immunity and Cancer. , 2019, Immunity.

[15]  Shujiro Okuda,et al.  SMAD4 alteration associates with invasive‐front pathological markers and poor prognosis in colorectal cancer , 2019, Histopathology.

[16]  Min Gyu Lee,et al.  SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesis , 2018, Nature Cell Biology.

[17]  Yanqiu Yuan,et al.  Protein Arginine Methyltransferase 5 (PRMT5) as an Anticancer Target and Its Inhibitor Discovery. , 2018, Journal of medicinal chemistry.

[18]  M. Ferrari,et al.  SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy , 2018, Clinical Cancer Research.

[19]  C. Deng,et al.  The role of TGF-β/SMAD4 signaling in cancer , 2018, International journal of biological sciences.

[20]  A. Tolcher,et al.  Abstract CT038: A phase I, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK3326595 in subjects with solid tumors and non-Hodgkin's lymphoma , 2017 .

[21]  B. Kessler,et al.  Protein arginine methylation: a prominent modification and its demethylation , 2017, Cellular and Molecular Life Sciences.

[22]  S. Richard,et al.  Arginine Methylation: The Coming of Age. , 2017, Molecular cell.

[23]  Xin-Hua Feng,et al.  Posttranslational Regulation of Smads. , 2016, Cold Spring Harbor perspectives in biology.

[24]  D. Shechter,et al.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond , 2015, Cellular and Molecular Life Sciences.

[25]  Yusuke Nakamura,et al.  Critical roles of non-histone protein lysine methylation in human tumorigenesis , 2015, Nature Reviews Cancer.

[26]  S. Li,et al.  Non-histone protein methylation as a regulator of cellular signalling and function , 2014, Nature Reviews Molecular Cell Biology.

[27]  Scott M. Carlson,et al.  Emerging technologies to map the protein methylome. , 2014, Journal of molecular biology.

[28]  D. Busam,et al.  SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. , 2013, Cancer research.

[29]  D. Patel,et al.  A Poised Chromatin Platform for TGF-β Access to Master Regulators , 2011, Cell.

[30]  C. Heldin,et al.  Negative Regulation of TGFβ Signaling by the Kinase LKB1 and the Scaffolding Protein LIP1* , 2010, The Journal of Biological Chemistry.

[31]  D. Franc,et al.  SMAD4 Immunohistochemistry Reflects Genetic Status in Juvenile Polyposis Syndrome , 2010, Clinical Cancer Research.

[32]  Hyun-A Seong,et al.  Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-β Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins* , 2010, The Journal of Biological Chemistry.

[33]  K. Helin,et al.  Histone methyltransferases in cancer. , 2010, Seminars in cell & developmental biology.

[34]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[35]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[36]  S. Lens,et al.  Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis , 2008, Gut.

[37]  Wei He,et al.  Hematopoiesis Controlled by Distinct TIF1γ and Smad4 Branches of the TGFβ Pathway , 2006, Cell.

[38]  K. Miyazono,et al.  Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* , 2005, Journal of Biological Chemistry.

[39]  Jonathan G. Rud,et al.  Nuclear Targeting of Transforming Growth Factor-β-activated Smad Complexes* , 2005, Journal of Biological Chemistry.

[40]  M. Rugge,et al.  Germ-Layer Specification and Control of Cell Growth by Ectodermin, a Smad4 Ubiquitin Ligase , 2005, Cell.

[41]  R. Derynck,et al.  Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling* , 2003, Journal of Biological Chemistry.

[42]  F. Melchior,et al.  Activation of Transforming Growth Factor-β Signaling by SUMO-1 Modification of Tumor Suppressor Smad4/DPC4* , 2003, Journal of Biological Chemistry.

[43]  C. Hill,et al.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. , 2002, Molecular cell.

[44]  Takeo Iwama,et al.  Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis , 1999, Oncogene.

[45]  W. Bodmer,et al.  Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Yigong Shi,et al.  A structural basis for mutational inactivation of the tumour suppressor Smad4 , 1997, Nature.

[47]  P. ten Dijke,et al.  Targeting TGF-β Signaling in Cancer. , 2017, Trends in cancer.

[48]  Xin-Hua Feng,et al.  Phospho-control of TGF-β superfamily signaling , 2009, Cell Research.